Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Strata Critical Medical (SRTAW) Assets Average (2019 - 2025)

Historic Assets Average for Strata Critical Medical (SRTAW) over the last 7 years, with Q3 2025 value amounting to $296.5 million.

  • Strata Critical Medical's Assets Average rose 527.65% to $296.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $296.5 million, marking a year-over-year increase of 527.65%. This contributed to the annual value of $275.8 million for FY2024, which is 1102.49% down from last year.
  • According to the latest figures from Q3 2025, Strata Critical Medical's Assets Average is $296.5 million, which was up 527.65% from $254.2 million recorded in Q2 2025.
  • Strata Critical Medical's 5-year Assets Average high stood at $344.8 million for Q3 2021, and its period low was $253.6 million during Q1 2025.
  • Over the past 5 years, Strata Critical Medical's median Assets Average value was $312.5 million (recorded in 2021), while the average stood at $304.2 million.
  • Its Assets Average has fluctuated over the past 5 years, first surged by 13288.52% in 2021, then plummeted by 1237.01% in 2024.
  • Strata Critical Medical's Assets Average (Quarter) stood at $339.6 million in 2021, then dropped by 4.06% to $325.8 million in 2022, then dropped by 6.02% to $306.2 million in 2023, then decreased by 11.89% to $269.8 million in 2024, then grew by 9.89% to $296.5 million in 2025.
  • Its Assets Average stands at $296.5 million for Q3 2025, versus $254.2 million for Q2 2025 and $253.6 million for Q1 2025.